Skip to main content
. 2023 Jul 20;11(2):890–920. doi: 10.1016/j.gendis.2023.06.017

Table 2.

Different mechanisms in regulating mRNA processes by IGF2BPs in cancers.

IGF2BPs Cancer Target mRNA Mechanisms of IGF2BPs in RNA processes Roles of mRNA in cancers References
1 Breast cancer KRT7 Serve as an m6A reader to promote mRNA stabilization Promote breast cancer lunger metastasis 10
1 Lung adenocarcinoma CTNNB1 Promote mRNA stabilization Oncogene 101
1 GC SEC62 Serve as an m6A reader to promote mRNA stabilization Promote GC proliferation and inhibit cell apoptosis 234
1 CRC β-TrCP1 Prevent miRNA-dependent degradation Serve as substrate recognition subunit of E3 ubiquitin ligase 120
1 CRC LDHA Bind to the 3′UTR of LDHA mRNA Promote glycolysis 171
1 HCC YES1 Serve as an m6A reader to promote mRNA stabilization Oncogene 15
1 HCC LYPD1 Stabilize mRNA in an m6A-dependent manner Promote tumorigenesis 122
1 HCC MKI67 Promote mRNA stabilization Promote cell proliferation and inhibit cell apoptosis 235
1 HCC GLI1 Promote mRNA stabilization Promote cell proliferation and metastasis 112
1 HCC, ovarian cancer, lung cancer SRF Serve as an m6A reader and impair miRNA-dependent degradation Enhance expression of genes that promote aggressive cancer phenotype 11
1 HCC, PC, ovarian cancer, melanoma, lung cancer, E2F Rely on 3′UTR-, miRNA-, and m6A-dependent to stabilize it Promote G1/S cell cycle transition 13
1 Melanoma, ovarian cancer eEF2 \ Enhance basal proliferation rates 223
1 Ovarian cancer MDR1 Promote mRNA stabilization Regulate chemoresistance 64
1 Ovarian cancer SIRT1 Prevent miRNA-dependent degradation Promote anoikis-resistance 118
1 Ovarian clear cell carcinoma let-7 target mRNA (IGF2BP1, HMGA2, LIN28B) Sequester mRNA into mRNP that do not contain RISC to stabilize it Promote cancer cell growth and self-renewal 116
1 Endometrial cancer SOX2 Serve as an m6A reader to promote mRNA stabilization An oncogenic transcriptional factor 153
1 Endometrial cancer PEG10 Serve as an m6A reader to promote mRNA stabilization Promote cell cycle and cancer progression 159
1 Choriocarcinoma RSK2, PPME1 Promote mRNA stabilization Promote cell migration and invasion 236
1 Osteosarcoma c-MYC Sequester mRNA into mRNP that do not contain RISC to stabilize it Promote cancer cell proliferation 7
1 Seminoma TFAP2C Serve as an m6A reader to promote mRNA stabilization Increase resistance to cisplatin 163
1 Breast cancer E-cadherin, β-actin, α-actinin, Arp2/3 Promote mRNA localization Stabilize cell–cell connections and focal adhesions 128
1 Osteosarcoma, ovarian cancer PTEN Bind to a rare codon-comprising fragment of the PTEN ORF to stabilize it Modulate cell polarization 134
1 Osteosarcoma, ovarian cancer, tumor-derived cells MAPK4 Inhibit mRNA translation through binding to MAPK4 3′UTR Promote cell adhesion and migration 134,237
1 Rhabdomyosarcomas cIAP1 Promote mRNA translation Mediate apoptotic resistance 130
1 HCC HCV Promote mRNA translation \ 131
1 OSCC BMI1 Promote mRNA translation in an m6A-dependent manner Promote cell proliferation and metastasis 12
1/2/3 cervical cancer, HCC MYC Serve as an m6A reader to promote mRNA stabilization Promote cancer proliferation, migration, and invasion 4
2 HNSCC SLUG Serve as an m6A reader to promote mRNA stabilization Lymphatic metastasis and EMT 238
2 PTC APOE Serve as an m6A reader to promote mRNA stabilization Mediate glycolysis 183
2 Radioiodine-refractory papillary thyroid cancer RUNX2 Serve as an m6A reader to promote mRNA stabilization Block the differentiation of radioiodine-refractory papillary thyroid cancer 239
2 Breast cancer DROSHA Serve as an m6A reader to promote mRNA stabilization Maintain breast cancer stem-like cell stemness 18
2/3 LUAD VANGL1 Serve as an m6A reader to promote mRNA stabilization Mitigate the effects of radiation on LUAD by increasing genes about DNA repair after the damage 167
2 Lung cancer TK1 Serve as an m6A reader to promote mRNA stabilization Promote angiogenesis 42
2 GC ZEB1 LINC01559 recruits IGF2BP2 to stabilize ZEB1 mRNA Serve as a transcription factor to combine with LINC01559, and promote cell proliferation, migration, and EMT 94
2 HCC FEN1 Serve as an m6A reader to promote mRNA stabilization Promote HCC growth 32
2 PDAC GLUT1 Bind to the middle of GLUT1 mRNA and promote mRNA stabilization Promote glycolysis and proliferation 182
2 CRC KLF4 Serve as an m6A reader to promote mRNA stabilization A cancer suppressor gene; regulates intestinal epithelial homeostasis 240
2 CRC SOX2 Serve as an m6A reader to promote mRNA stabilization Promote stemness features and metastatic 152
2 CRC MTA1 Serve as an m6A reader to promote mRNA stabilization Promote cancer migration and invasion 181
2 CRC RAF-1 Prevent miRNA-dependent degradation Promote cancer proliferation and survival 121
2 CRC HK2 Bind to the 5′UTR/3′UTR of HK2 mRNA as an m6A reader to promote mRNA stabilization Promote glycolysis and proliferation 185
2 CRC MSX1, JARID2 LINC021 enhances its role as an m6A reader to promote mRNA stabilization Promote tumorigenesis 241
2 Ovarian cancer FGF9 Promote mRNA stabilization Induce chemoresistance and the polarization of TAMs toward the M2 phenotype 104
2 Prostate cancer IGF1r The mRNA stabilization may be related to m6A modification Promotes bone metastasis and cancer growth 96
2 Prostate cancer LDHA Bind to the 3′UTR of LDHA mRNA to promote mRNA stabilization Promote glycolysis 93
2 Malignant embryonic rhabdoid tumor, cervical cancer, breast cancer, HCC, CRC, lung cancer HMGA1 Bind to the 3′UTR of HMGA1 mRNA to promote mRNA stabilization and may be related to m6A modification An oncogene; promote cancer proliferation, migration, and invasion 81,105
2 Glioblastoma let-7 target mRNA (IGF2BP3, HMGA1, HMGA2, CCND1) Prevent miRNA-dependent degradation Preserve glioblastoma stem cell 119
2 Glioblastoma CI/CIV Promote the mRNA activity Regulate OXPHOS 137
2 embryonic rhabdomyosarcoma NRAS Promote mRNA stabilization oncogene 242
2 Embryonic rhabdomyosarcoma IGF2 Promote mRNA translation \ 80
2 Radioiodine-refractory papillary thyroid cancer ERBB2 Increase translation efficacy through binding to the m6A methylation site Contribute to acquired resistance to TKI 133
3 NPC KPNA2 Serve as an m6A reader to promote mRNA stabilization Promote proliferation and metastasis 40
1/3 Cervical cancer CD44 Stabilize the 5.0 kb CD44 mRNA Promote invadopodia formation 129
3 Breast cancer CD44 Regulate CD44 promoter activity Promote cell proliferation, maintain stemness, and induce chemotherapy resistance 179
3 Breast cancer PD-L1 Serve as an m6A reader to promote mRNA stabilization Inhibit cancer immune surveillance 174
3 Breast cancer IGF2, MMP9, CD164 Bind to the mRNA and promote mRNA stabilization Involve in migration and invasion 41
3 Breast cancer CERS6 Promote mRNA stabilization Promote cell proliferation, suppress cell apoptosis 102
3 Breast cancer ABCG2 Bind to ABCG2 mRNA and regulate its expression Promote cell invasion 243
3 Esophageal cancer KIF18A Stabilize KIF18A mRNA Promote cancer proliferation and migration and is associated with radioresistance 244
3 GC HDGF Serve as an m6A reader to promote mRNA stabilization Secrete HDGF promotes cancer angiogenesis; nuclear HDGF increases glycolysis 14
3 GC HIF1A Serve as an m6A reader to promote mRNA stabilization Promote cell migration and angiogenesis 180
3 HCC pgRNA Promote mRNA stabilization in an m6A-independent manner Promote HCC proliferation, stemness, and tumorigenicity 67
3 HCC TRAF5 Promote mRNA stabilization Promote cell proliferation and metastasis 103
3 CRC KRAS, MAP2K1, TPR, CCNH Promote mRNA stabilization with the help of ELAVL1 Promote cancer proliferation 245
3 CRC ABCB1 Serve as an m6A reader to promote mRNA stabilization Promote cancer chemoresistance 246
3 CRC CCND1 Serve as an m6A reader to promote mRNA stabilization Promote cell cycle 160
3 CRC VEGF Serve as an m6A reader to promote mRNA stabilization Promote angiogenesis 160
2/3 CRC GLUT1 Bind to 3′UTR of GLUT1 mRNA as an m6A reader Promote glycolysis and proliferation 185
3 PDAC HK2 Promote mRNA stabilization Participate glycolysis 184
3 Hematopoietic progenitor cell CDK6, MYC Stabilize the mRNA and/or enhance translation Oncogene 247
3 ccRCC CDK4 Serve as an m6A reader to promote mRNA stabilization Is associated with the G1/S transition 95
3 Cervical cancer, HCC PDK4 Serve as an m6A reader to promote mRNA stabilization Promote glycolysis and ATP generation 186
3 Acute myeloid leukemia COX2 Bind to the 3′UTR of mRNA to promote mRNA stabilization Inhibit cell apoptosis 233
1/3 Myeloid leukemia MYC, BCL2 Promote stability of m6A-modified mRNA with the help of YBX1 Maintain the myeloid leukemia cell survival 90
3 AML RCC2 Serve as an m6A reader to promote mRNA stabilization Promote AML progression 248
3 Human cancer cells CCND1, CCND3, CCNG1 Cooperate with HNRNPM to regulate post-transcriptional expression Accelerate cell proliferation 136
3 Ewing sarcoma CD164 Bind to the mRNA to regulate its expression Promote cancer invasion 249
3 Some kinds of solid cancers and fibrosarcoma HMGA2, LIN28B Sequester mRNA into mRNP that did not contain RISC Oncogene 117
3 PDAC 164 direct targe mRNA contained HMGA2, ZFP36L1, DCBLD2, CLDN1, CD44, ANTRX1, CLDN1, OLR1 Bind to Ago2 (a RISC component) and act as a bi-modal regulator of mRNA stability Promote cell migration, proliferation, and remodel focal adhesion 123
3 HCC ZO-1 Enhance Ago2-mRNA interactions to inhibit ZO-1 expression Down-regulation of ZO-1 promotes cancer metastasis and invasion 250
3 LUAD EIF4E-BP2 Serve as an RNA-destabilizing factor to promote EIF4E-BP2 mRNA degradation Promote EIF4E-mediated translation activation 125
3 CRC ULBP2 Bind to the 3′UTR of ULBP2 mRNA to destabilize it Enable immune cells to recognize and destroy cells that express it 124
2/3 TNBC PR Recruit CNOT1 to destabilize PR mRNA Promote the metastasis 47

AML: acute myeloid leukemia; CRC: colorectal cancer; GC: gastric cancer; HCC: hepatocellular carcinoma; HNSCC: head and neck squamous cell carcinoma; LUAD: lung adenocarcinoma; NPC: nasopharyngeal carcinoma; OSCC, oral squamous cell carcinoma; PC, pancreatic cancer; PDAC: pancreatic ductal adenocarcinoma; PTC: papillary thyroid cancer; TNBC: triple-negative breast cancer.